Successful Treatment of Combined Large Cell Neuroendocrine Carcinoma Harboring an EGFR Mutation with EGFR-TKIs plus Bevacizumab: A Case Report

Large cell neuroendocrine carcinoma (LCNEC) of the lung with epidermal growth factor receptor (EGFR) mutation is rare, and few cases have been treated with EGFR tyrosine kinase inhibitors (TKIs). We report the treatment of combined LCNEC with adenocarcinoma harboring an EGFR mutation with EGFR-TKIs...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Case Rep Oncol
Main Authors: Muto, Satoshi, Ozaki, Yuki, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Shio, Yutaka, Hashimoto, Yuko, Suzuki, Hiroyuki
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger AG 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772843/
https://ncbi.nlm.nih.gov/pubmed/33442360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000511112
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares